Role of Blood-Brain Barrier in Alzheimer’s Disease
The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Abstract
The blood-brain barrier (BBB) is involved in the pathogenesis of Alzheimer's disease (AD). BBB is a highly selective semipermeable structural and chemical barrier which ensures a stable internal environment of the brain and prevents foreign objects invading the brain tissue. BBB dysfunction induces the failure of Aβ transport from brain to the peripheral circulation across the BBB. Especially, decreased levels of LRP-1 (low density lipoprotein receptor-related protein 1) and increased levels of RAGE (receptor for advanced glycation endproducts) at the BBB can cause the failure of Aβ transport. The pathogenesis of AD is related to the BBB structural components, including pericytes, astrocytes, vascular endothelial cells, and tight junctions. BBB dysfunction will trigger neuroinflammation and oxidative stress, then enhance the activity of β-secretase and γ-secretase, and finally promote Aβ generation. A progressive accumulation of Aβ in brain and BBB dysfunction may become a feedback loop that gives rise to cognitive impairment and the onset of dementia. The correlation between BBB dysfunction and tau pathology has been well-reported. Therefore, regulating BBB function may be a new therapeutic target for treating AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661 · cited 2×
“TheBBBhasthemostimpor-tantroleinmaintainingbrainfunctionamongthe threebrainbarriers[14,15].”
The blood–brain barrier: an overview
Ballabh, P., Braun, A., & Nedergaard, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.016 · Cited by 2,261
Blood-brain barrier breakdown in the aging human hippocampus
Montagne, A., Barnes, S. R., Sweeney, M. D., Halliday, M. R., Sagare, A. P., Zhao, Z., Toga, A. W., Jacobs, R. E., Liu, C. Y., Amezcua, L., et al. (2015) · Neuron · doi:10.1016/j.neuron.2014.12.032 · Cited by 2,102
Establishment and Dysfunction of the Blood-Brain Barrier
Zhao, Z., Nelson, A. R., Betsholtz, C., & Zlokovic, B. V. (2015) · Cell · doi:10.1016/j.cell.2015.10.067 · Cited by 1,670 · cited 1×
“Pericytes, an important component of neurovascular unit and BBB, act like the gatekeepers of the BBB, and exquisitely regulate the movement of brain cellsandthetransportationofnutrientsandmoleculesbetweenthebloodandthebraininterstitialfluidthatsurroundsthebraincells [87–89].”
RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain
Deane, R., Du Yan, S., Submamaryan, R. K., LaRue, B., Jovanovic, S., Hogg, E., Welch, D., Manness, L., Lin, C., Yu, J., et al. (2003) · Nature Medicine · doi:10.1038/nm890 · Cited by 1,611
Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier
Huber, J. D., Egleton, R. D., & Davis, T. P. (2001) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02004-x · Cited by 786 · cited 1×
“…or progression of numerous brain diseases, such as hemorrhagic and ischemic stroke, intracranial infectious diseases, intracranial autoimmune diseases, epilepsy, lupus cerebritis, and brain tumors [105, 106], as well as neurodegenerative diseases like Parkinson’s disease and AD [45, 107].”
The blood-brain barrier in Alzheimer’s disease
Zenaro, E., Piacentino, G., & Constantin, G. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.07.007 · Cited by 767 · cited 7×
“Second,A (cid:2) pathology suffering from BBB dysfunction can indirectly facilitate the onset of tau pathology, representing a mechanistic link between A (cid:2) /tau deposition after BBB dysfunction [1, 126].”
InfluentialAlzheimer’s disease: A matter of blood–brain barrier dysfunction?
Montagne, A., Zhao, Z., & Zlokovic, B. V. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20171406 · Cited by 672 · cited 2×
“528 Yet, the role of BBB in the pathogenesis of AD is 529 still a challenge [12, 132].”
Bell, R. D., Sagare, A. P., Friedman, A. E., Bedi, G. S., Holtzman, D. M., Deane, R., & Zlokovic, B. V. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600419 · Cited by 670
Halliday, M. R., Rege, S. V., Ma, Q., Zhao, Z., Miller, C. A., Winkler, E. A., & Zlokovic, B. V. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.44 · Cited by 649
Research works printed but not linked: 1
- Volpina, 2015, [Fragment of receptor for advanced glycation end products improves memory state in a model of Alzheimer’s disease, Bioorg Khim, 41, 709
Cited by
Items 201–300 of 376
Life-long arsenic exposure damages the microstructure of the rat hippocampus
Niño, S. A., Chi-Ahumada, É., Carrizales, L., Estrada‐Sánchez, A. M., González-Billault, C. E., Zarazúa, S., Concha, L., & Jiménez-Capdeville, M. E. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147742 · Cited by 10
Increased Permeability of the Blood–Brain Barrier in a Diabetic Mouse Model (Leprdb/db Mice)
Alshammari, M. A., Alshehri, A. O., Alqahtani, F., Khan, M. R., Bakhrebah, M. A., Alasmari, F. F., Alshammari, T. K., & AlSharari, S. D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147768 · Cited by 12
“Most of them share a unifying feature: a disruption in the dynamics and structure of the BBB [17–23].”
BackgroundWang, X., Yang, J., Zhang, X., Cai, J., Zhang, J., Cai, C., Zhuo, Y., Fang, S., Xu, X., Wang, H., et al. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156158 · Cited by 12
Lu, Q., Meng, Y., Feng, H., Di, X., & Guo, X. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47040226 · Cited by 12
“Dysfunction of the blood-brain barrier (BBB) triggers neuroinflammation and oxidative stress, which subsequently enhance the activities of β -secretase and γ -secretase, ultimately promoting A β production [58].”
Sharma, N., Kim, D., Sharma, H., Kim, M. I., Lee, H., Kim, M., Ryoo, N., Kang, M. J., Pyun, J., Park, Y. H., et al. (2025) · Biomarker Research · doi:10.1186/s40364-025-00829-4 · Cited by 10
“BBB dysfunction triggers neuroinflammation and oxidative stress, which in turn enhances the activity of β-secretase and γ-secretase, leading to increased Aβ production [17, 18].”
Liu, Y., Dong, Y., Cao, Z., Ji, Y., Cheng, X., & Zheng, X. (2025) · Nutrients · doi:10.3390/nu17213451 · Cited by 12
“BBB dysfunction, particularly decreased levels of low-density lipoprotein receptor-associated protein 1 (LRP1) and elevated levels of receptor for advanced glycation end-products (RAGE) in the BBB, impairs the transport of A β from the brain across the BBB into the peripheral circulation [19].”
Maugeri, A., Russo, C., Patanè, G. T., Barreca, D., Mandalari, G., & Navarra, M. (2023) · Molecules · doi:10.3390/molecules28247949 · Cited by 10
“Each sample was filtered through an Iso-Disc P-34, 3 mm diameter PTFE membrane, and 0.45 µ m pore size (Supelco, Bellefonte, PA, USA) prior to RP-HPLC-DAD separation.”
MethodInfluentialAging-Related and Gender Specific Albumin Misfolding in Alzheimer’s Disease
Tsao, F. H. C., Barnes, J. N., Amessoudji, A., Li, Z., & Meyer, K. C. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200168 · Cited by 11
“Dysfunction of the blood-brain-barrier (BBB) is associated with the pathogenesis of AD and other neurodegenerative diseases [25].”
BackgroundTriggering Innate Immune Receptors as New Therapies in Alzheimer’s Disease and Multiple Sclerosis
Piec, P.-A., Pons, V., & Rivest, S. (2021) · Cells · doi:10.3390/cells10082164 · Cited by 11
Vavougios, G. D., Nday, C. M., Pelidou, S., Zarogiannis, S. G., Gourgoulianis, K. I., Stamoulis, G. I., & Doskas, T. K. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2020.08.021 · Cited by 10
Past, Present, and Future of Liver-Brain Axis in Alzheimer’s Disease: A Bibliometric Review
Liu, X. L., Yeerlan, J., Liu, Z., Bai, Y., Wang, Q., Yan, Y., Xu, L., Cui, J., & Zhang, L. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240688 · Cited by 10
“50 , 51 It is essential for clearing A (cid:2) from the brain and throughout the body.”
Chauhan, P., Wadhwa, K., & Singh, G. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156109 · Cited by 12
Zhang, H., Xu, Q., Ye, M., Wu, X., Ren, Z., Qin, L., Tang, Z., Wang, G., Xiang, Q., & Liu, L. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.01.045 · Cited by 12
Saverimuttu, S. C. C., Kramarz, B., Rodríguez-López, M., Garmiri, P., Attrill, H. L., Thurlow, K. E., Makris, M., Pinheiro, S. D. M., Orchard, S. E., & Lovering, R. C. (2021) · Database · doi:10.1093/database/baab067 · Cited by 7
Forgham, H., Liu, L., Zhu, J., Javed, I., Cai, W., Qiao, R., & Davis, T. P. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215172 · Cited by 10
Rastogi, V., Jain, A., Kumar, P., Yadav, P., Porwal, M., Chaturvedi, S., Chandra, P., & Verma, A. K. (2023) · Journal of drug targeting · doi:10.1080/1061186x.2023.2238250 · Cited by 10
“Fundamentally, BBB dysfunction affects the proper clearance of the Amyloid-β from the cNS to PNS [26].”
BackgroundSensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism
Hu, J., Zheng, L., Guan, Z., Zhong, K., Huang, F., Huang, Q., Yang, J., Li, W., & Li, S. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110750 · Cited by 10
“glycosylation end product-specific receptor (RAGE)[49-51].”
Zhou, M., Fu, X., Ma, B., Chen, Z., Cheng, Y., Liu, L., Kan, S., Zhao, X., Feng, S., Jiang, Z., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1274642 · Cited by 9
Chun, M. Y., Jang, H., Kim, H. J., Kim, J. P., Gallacher, J., Allué, J. A., Sarasa, L., Castillo, S., Pascual‐Lucas, M., Na, D. L., et al. (2023) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2023.1126799 · Cited by 9
Serum amyloid beta 42 levels correlated with metabolic syndrome and its components
Li, K., Zhou, X., Liu, Y., Li, D., Li, Y., Zhang, T., Fu, C., Li, L., Hu, Y., & Jiang, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1278477 · Cited by 12
“LRP1 on the BBB is responsible for transporting A b from the CSF to the periphery, while receptors for advanced glycation end products (RAGE) can transport peripheral A b into the brain parenchyma (54).”
BackgroundBridging the Gap: The Neuro-immune Axis as a Key Player in Neurodegenerative Disorders
Liu, T., Wu, H., & Wei, J. (2025) · Neuroscience Bulletin · doi:10.1007/s12264-025-01439-8 · Cited by 10
“Astrocytes play a crucial role in the formation and maintenance of the BBB [50].”
Dang, L., Wei, S., Zhao, Y. C., Zhou, R., Shang, S., Gao, F., Wang, J., Wang, J., & Qu, Q. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02398-1 · Cited by 8
Yang, J., Betterton, R. D., Williams, E. I., Stanton, J. A., Reddell, E. S., Ogbonnaya, C. E., Dorn, E., Davis, T. P., Lochhead, J. J., & Ronaldson, P. T. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14050949 · Cited by 11
Ray, R., Chowdhury, S. G., & Karmakar, P. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.109906 · Cited by 8
Circular RNA aptamers ameliorate AD-relevant phenotypes by targeting PKRPreprint
Feng, X., Jiang, B., Zhai, S.-N., Liu, C., Wu, H., Zhu, B.-Q., Wei, M.-Y., Wei, J., Yang, L. C., & Chen, L. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.27.583257 · Cited by 8
“Moreover, microglial (CD11b + ) are the major contributors to neuroinflammation 29, 30 , secreting pro-2 inflammatory cytokines dozens of times higher than CD11b - samples in 5 ´ FAD mice (Extended Data Fig.8a).”
BackgroundUltra-thin and ultra-porous nanofiber networks as a basement-membrane mimic
Graybill, P. M., Jacobs, E. J., Jana, A., Agashe, A., Nain, A. S., & Davalos, R. V. (2023) · Lab on a Chip · doi:10.1039/d3lc00304c · Cited by 9
Basic approach on the protective effects of hesperidin and naringin in Alzheimer’s disease
Kuşi, M., Becer, E., & Vatansever, S. (2024) · Nutritional Neuroscience · doi:10.1080/1028415x.2024.2397136 · Cited by 8
“BBB dysfunction may also increase Aβ formation by triggering inflammation and oxidative stress [57].”
Stress-induced regional characteristics of the blood-brain barrier
Zhou, M.-Y., Xie, F., Zhao, Y. F., Wang, X., Sun, Z., & Qian, L. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111548 · Cited by 9
Hydrogel-based microfluidic model of the blood-brain barrier: progress and future perspectives
Guo, F., Chen, J., Wang, L., Li, M., Lv, Q., Wang, J., Hong, W., & Yang, G. (2025) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00727-9 · Cited by 7
“…barrier is critical for maintaining CNS homeostasis through several mechanisms [9], including regulating the transport of molecules and ions [10, 11], shielding the brain from toxins and pathogens [12], and preventing inappropriate immune responses that could lead to various brain diseases [13].”
Targeting Alzheimer's pathophysiology with carbon dots: from mechanisms to therapy
Tripathi, S., Singh, R., Jaiswal, S., Sethi, M., Rana, R., Mishra, K., & Chourasia, M. K. (2026) · Journal of Materials Chemistry B · doi:10.1039/d5tb02134k · Cited by 8
Gliovascular interface abnormality in mice with endothelial cell senescence
Kawauchi, S., Mizoguchi, T., Horibe, S., Tanaka, T., Sasaki, N., Ikeda, K., Emoto, N., Hirata, K., & Rikitake, Y. (2022) · Glia · doi:10.1002/glia.24287 · Cited by 7
“eases, including Alzheimer's disease (Cai et al., 2018; Sweeney et al., 2018; Zenaro et al., 2017).”
BackgroundAquino, G. V., Dabi, A., Odom, G., Lavado, R., Nunn, K. L., Thomas, K., Schackmuth, B., Shariff, N., Jarajapu, M., Pluto, M., et al. (2023) · Current Research in Toxicology · doi:10.1016/j.crtox.2023.100107 · Cited by 8
“In the context of AD, previous studies have demonstrated the association between disease progression and BBB dysfunction, specifically through altered P-gp function (Cai et al., 2018; Kuhnke et al., 2007; McCormick et al., 2021; van Assema et al., 2012).”
BackgroundCrosstalk between peripheral immunity and central nervous system in Alzheimer’s disease
Yang, H.-C., Qin, Q., Wang, M., Yin, Y., Li, R., & Tang, Y. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104743 · Cited by 12
Altering distribution profile of palbociclib by its prodrugs
Järvinen, J., Montaser, A. B., Adla, S. K., Leppänen, J., Lehtonen, M., Vellonen, K., Laitinen, T., Jalkanen, A. J., Elmquist, W. F., Timonen, J. M., et al. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106637 · Cited by 7
Potential Use of Agave Genus in Neuroinflammation Management
Herrera-Ruiz, M. L., Jiménez‐Ferrer, E., González‐Cortazar, M., Zamilpa, A., Cardoso-Taketa, A., Arenas-Ocampo, M. L., Jiménez–Aparicio, A. R., & Monterrosas‐Brisson, N. (2022) · Plants · doi:10.3390/plants11172208 · Cited by 11
Air pollution as a key risk factor for alzheimer’s disease: A comprehensive review
Zhu, X., Guo, C., Zhang, Y., & Wei, Y. (2025) · Environmental Technology & Innovation · doi:10.1016/j.eti.2025.104555 · Cited by 6
Colpitts, K. N., & Grau, J. W. (2026) · Cells · doi:10.3390/cells15030232 · Cited by 7
“In addition to neural injuries, other reviews have noted a relationship between barrier disruption and neuropathologies such as epilepsy [7,8], ischemic stroke [9], and Alzheimer’s disease [10].”
Investigation into the vascular contributors to dementia and the associated treatments
Davidson, C. G., Woodford, S. J., Mathur, S., Valle, D., Foster, D. T., Kioutchoukova, I. P., Mahmood, A., & Lucke-Wold, B. P. (2023) · Exploration of neuroscience · doi:10.37349/en.2023.00023 · Cited by 6
Xu, Y., Zhang, J., & Li, X. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1328334 · Cited by 9
“AGEs can bind to various cell surface receptors, notably the receptor for advanced glycation end products (RAGE), a pattern recognition receptor (Neeper et al., 1992; Cai et al., 2018).”
BackgroundRamli, S. M. A. Z., Hamid, H. A., Nassir, C. M. N. C. M., Rahaman, S. N. A., Mehat, M. Z., Kumar, J., Lee, S., & Mustapha, M. (2024) · Vessel Plus · doi:10.20517/2574-1209.2024.22 · Cited by 13
Interpreting the Therapeutic Efficiency of Multifunctional Hybrid Nanostructure against Glioblastoma
Ou, Z., Li, X., You, Y., Liu, D., & Wang, J. (2023) · ACS Omega · doi:10.1021/acsomega.2c08265 · Cited by 6
Inflammation-Mediated Responses in the Development of Neurodegenerative Diseases
Nainu, F., Mamada, S. S., Harapan, H., & Emran, T. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-981-19-7376-5_3 · Cited by 6
Zhang, L., Zhu, B., Zhou, X., Hao, N., Zhang, F., Yan, B., Chen, J., & Ma, T. (2024) · Neurotoxicity Research · doi:10.1007/s12640-024-00693-4 · Cited by 6
“However, these biological features of the BBB also present as significant obstacles to treat injured or damaged brain (Saraiva et al. 2016; Cai et al. 2018).”
Kane, E. I., Waters, K. L., & Spratt, D. E. (2021) · Cells · doi:10.3390/cells10082121 · Cited by 7
“Abnormalities within the BBB and CW have recently been reported in specific AD cases such as increased atherosclerosis in CW and the accumulation of tau and amyloid beta (Aβ) from BBB-induced neuroinflammation [42,43].”
BackgroundDing, Y., Shusta, E. V., & Palecek, S. P. (2021) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2021.100341 · Cited by 8
A Novel Perspective on PCSK9 in Alzheimer’s Disease: A Focus on Amyloid Beta
Zhang, H., Xu, Q. F., Zhao, Y., He, N., Ren, Z., Xiang, Q., Tang, Z., & Liu, L. (2024) · Current Medicinal Chemistry · doi:10.2174/0109298673269288231123095215 · Cited by 8
Akman, N., Coşkun, D., ÇERİBAŞI, S., & Ateşşahin, A. (2024) · Biological Trace Element Research · doi:10.1007/s12011-024-04417-9 · Cited by 7
“Recent studies have indicated that disruptions in neurogenesis within the DG can lead to ASD-like behaviors [53].”
The canine blood-brain barrier in health and disease: focus on brain protection
Bassalo, D., Matthews, S. G., & Bloise, E. (2025) · Veterinary Quarterly · doi:10.1080/01652176.2025.2450041 · Cited by 10
“BBB dysfunction is involved in the pathogenesis of Alzheimer’s disease due to a key role of the BBB in clearing amyloid-β protein from the brain (Cai et al. 2018).”
InfluentialBowirrat, A., Pinhasov, A., Bowirrat, A., & Badgaiyan, R. D. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178253 · Cited by 8
“We explain their function and their role in the neuroinflammation, the cell types and mediators involved in neuroinflammation and AD, the symptom manifestations in clinical settings, and potential candidates for improving diagnosis and treatment [326–328].”
Mohammad, S. I., Hammood, Y. M., Vasudevan, A., Uthirapathy, S., Ballal, S., Sabarivani, A., Mishra, S., Nathiya, D., Al‐qaim, Z. H., & KADHIM, A. J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05447-7 · Cited by 7
“…is linked to neurological diseases—such as Alzheimer’s, Parkinson’s, and Huntington’s—by emphasizing roles in regulating systemic inflammation, blood–brain barrier (BBB) permeability, oxidative stress, and neurotransmission promoting neurotoxic aggregate formation and chronic inflammation [154].”
Liu, R., Deng, Q., Gong, L., & Yang, L. (2026) · Neuroscience Bulletin · doi:10.1007/s12264-026-01598-2 · Cited by 6
“BBB dysfunction represents a key pathological feature of AD [158].”
New Insights into Depressive Disorder with Respect to Low-Grade Inflammation and Fish Oil Intake
Tung, T.-H., Nguyen, N. T. K., & Huang, S. (2021) · Journal of Oleo Science · doi:10.5650/jos.ess21209 · Cited by 5
Kingsley, R., Tyree, S., Jarsania, D., Edquist, C., Palmer, A. K., Gerberi, D., Wilfahrt, R. P., & Pagali, S. R. (2024) · International Neurourology Journal · doi:10.5213/inj.2448266.133 · Cited by 6
“As a complicating factor, dementia is associated with blood brain barrier dysfunction [40, 41].”
BackgroundBlood-Brain Barrier Dysfunction in the Detrimental Brain Function
González‐Candia, A., Rogers, N. K., & Castillo, R. L. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.94572 · Cited by 7
Influence of the Gut Microbiota on the Pathogenesis of Alzheimer’s Disease: A Literature Review
Batko, J., Antosz, K., Suchecki, W., Szyller, H. P., Wrześniewska, M., Dyda, M., & Leszek, J. (2025) · Cells · doi:10.3390/cells14201578 · Cited by 5
“…as blood–brain barrier dysfunction resulting from age-related vascular stress, whose compromised selectivity prevents the effective transport of beta-amyloid to the peripheral circulation, thereby increasing the rate of protein accumulation and, consequently, its pro-inflammatory effect [25].”
Zou, W., Yick, L.-W., Kwan, J., Zhang, Z., Xue, H., & Chan, K. H. (2026) · Alzheimer s Research & Therapy · doi:10.1186/s13195-026-01968-y · Cited by 5
“The BBB is a critical site of Aβ clearance from the brain to blood [58].”
Dysfunction of the neurovascular unit as a temporal driver in Alzheimer’s pathogenesis
Wang, L., Han, L., & Liu, S. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00548-2 · Cited by 7
“LRP-1 (Low-density lipoprotein receptor) is required for APOE-dependent Aβ clearance, and its reduced expression in AD patients may worsen Aβ pathology [66].”
Roamcharern, N., & Yubolphan, R. (2026) · Frontiers in Neuroscience · doi:10.3389/fnins.2026.1810486 · Cited by 5
“In AD, BBB integrity is often altered due to vascular dysfunction, inflammation, and cerebral amyloid angiopathy (Cai et al., 2018; Alkhalifa et al., 2023).”
Potential role of tanycyte-derived neurogenesis in Alzheimer’s disease
Qi, G., Tang, H., Hu, J., Kang, S., & Qin, S. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-23-01865 · Cited by 7
Amyloid Beta–Mediated Neurovascular Toxicity in Alzheimer’s Disease
Banerjee, S., & Banerjee, S. (2024) · Methods in molecular biology · doi:10.1007/978-1-0716-3662-6_26 · Cited by 6
Cell Type–Specific Nuclei Markers: The Need for Human Brain Research to Go Nuclear
Wiseman, J. A., Dragunow, M., & Park, T. (2021) · The Neuroscientist · doi:10.1177/10738584211037351 · Cited by 5
Cai, M., Chen, S., Du, Y., Li, S., Dong, P., Wang, L., Yang, R., Hu, J., & Zhu, L. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02052-4 · Cited by 4
Self-citationFrench, S. R., Arias, J., Bolakale‐Rufai, I. K., Zahra, S., Khakwani, K. Z. R., Bedrick, E. J., Serrano, G. E., Beach, T. G., Reiman, E. M., & Weinkauf, C. C. (2024) · JVS Vascular Science · doi:10.1016/j.jvssci.2024.100206 · Cited by 6
“6,7 The time course of BBB dysfunction after stroke may occur in two phases: acute and delayed.”
BackgroundCai, J., Liu, Y., Gong, L., Deng, S., Zheng, W.-H., & Li, S. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05141-8 · Cited by 3
“BBB injury caused by cerebrovascular dysfunction may induce the onset of AD [22].”
Role of non-neuronal cells in neurorepair: a focus on proteinopathy and neurodegeneration
Rodríguez-Carreiro, S., Nogales, M. D. C., Jiménez-Galán, D., Carmona-Lorenzo, S., Caro-Martín, A., Navarro, E., & Esteras, N. (2024) · Regenerative medicine reports . · doi:10.4103/regenmed.regenmed-d-24-00005 · Cited by 4
Immune cells: Mediators in the metabolites and Alzheimer’s disease
Zhang, E., Dai, F., Tao, L., Chen, Y., Chen, T., & Shen, X. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877241313140 · Cited by 3
“82 HLA-DR (MHC class II molecules), predominantly expressed on dendritic cells and macrophages, functions to present antigens to CD4 + T cells, initiating an immune cascade.”
Summanwar, D., Kim, H., Wei, J., Boustani, M. A., Alonso, Á., & Kulshreshtha, A. (2025) · Journal of Alzheimer s Disease Reports · doi:10.1177/25424823251370646 · Cited by 5
“22 Hemodynamic changes from atherosclerosis and arterial stenosis further reduce brain perfusion, exacer-bating ischemic damage.”
Exploring efficient and effective mammalian models for Alzheimer’s disease
Kayano, M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1652754 · Cited by 4
Application of Organ-on-Chip in Blood Brain Barrier Model
Vatsa, P., & Pant, A. B. (2022) · Springer eBooks · doi:10.1007/978-981-19-1379-2_24 · Cited by 3
Zhang, F., Mao, H., Zhu, J., Zhou, R., Zhang, L., & Jiang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1134239 · Cited by 4
Li, M., Gan, J., Yang, X., Liu, S., & Ji, Y. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1390036 · Cited by 4
“BBB dysfunction has been associated with PD, particularly in the striatum, substantia nigra, and white matter of the brain (Burgmans et al., 2013), and is thought to play a role in disease progression and be involved in the development of cognitive impairment (Cai et al., 2018, 2021).”
BackgroundAn overview on the impact of viral pathogens on Alzheimer's disease
AmeliMojarad, M., AmeliMojarad, M., & Cui, X. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102615 · Cited by 4
ABC Family Gene Polymorphisms and Cognitive Functions Interact to Influence Antidepressant Efficacy
Jin, M., Ji, L., Ran, M., Wang, Z., Bi, Y., Zhang, H., Tao, Y., Xu, H., Zou, S., Zhang, H., et al. (2024) · Pharmacopsychiatry · doi:10.1055/a-2437-1751 · Cited by 2
“Furthermore, the BBB role in cognitive function is evident as patients with cognitive impairment often exhibit BBB dysfunction, and cognitive function improvements post-administration of specific nutrients correlate with changes in BBB permeability [47, 48].”
Material considerations for delivering therapeutics across the blood–brain barrier
Zoba, A. N., & Tringides, C. M. (2025) · APL Materials · doi:10.1063/5.0284305 · Cited by 2
Shen, Z., Wu, M., Sun, S., Ling, Y., Chen, X., Zhang, J., Zhou, X., & Zhou, C. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120748 · Cited by 4
Marion, D., Li, Z., Roseborough, A. D., Whitehead, S. N., Freeman, E. E., Birnie, D. H., Elahi, F. M., Hachinski, V., Cushman, M., & Edwards, J. D. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.039636 · Cited by 6
Rozanova, N., Averchuk, A., Kapkaeva, M., Zhdankina, V., Makarov, V. I., Skobeltsin, A. S., Romanishkin, I. D., Baranich, T., & Salmina, A. (2026) · Bulletin of experimental biology and medicine · doi:10.1007/s10517-026-06648-3 · Cited by 1
“These findings may reflect altered astrocytic reactivity associated with AD pathology [7].”
Bhukta, P., Sahu, P. K., & Acharya, B. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100495 · Cited by 2
Convergence of neuroinflammation across major neurotropic viral exposomes in AD and ADRD
Harmouch, J., Green, R. J., Mayilsamy, K., Tosi, K., Mohapatra, S., & Mohapatra, S. S. (2026) · Journal of Neuroinflammation · doi:10.1186/s12974-026-03876-2 · Cited by 2
“Third, organoid-on-chip and multi-organ microfluidic systems extend these capabilities by modeling multi-tissue viral interactions, circulating immune components, and long-term, low-dose exposures [118, 139]. for dissecting tissue-tissue crosstalk under physiologic stressors [15, 29, 36, 100, 138].”
InfluentialCzubowicz, K., Motyl, J. A., Wencel, A., & Strosznajder, R. P. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27125200 · Cited by 2
Khalafi, M., Rashnoudi, A. R., Rahmani, F., Javanmardi, P., Panahi, P., Shahvandi, H. K., Tajik, M. H., Soleimantabar, H., & Shirbandi, K. (2023) · The Egyptian Journal of Radiology and Nuclear Medicine · doi:10.1186/s43055-023-00964-8 · Cited by 3
“Inflammation can potentially decrease the conduction of information between neurons [4, 5].”
BackgroundZanwar, A. A., Joshi, A., Gaikwad, P. S., & Hegde, M. V. (2024) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_17_23 · Cited by 2
Fight Aβ Aggregation with Molecular Aggregates
Wang, C. H., Zhang, D., Hu, M., & Wang, X. (2025) · Macromolecular Chemistry and Physics · doi:10.1002/macp.202400531 · Cited by 2
Xia, C., & Ma, Q. (2021) · Computational and Mathematical Methods in Medicine · doi:10.1155/2021/7135399 · Cited by 3
“Cognitive function and memory deterioration are the main characteristics of the disease, accompanied by mental and psychological symptoms, and prone to abnormal behaviors such as depression, irritability, and anxiety [2].”
BackgroundRetractedApplication of Nanomaterials in Neurodegenerative Diseases
Cui, W., Fu, W., Zhang, T., Zhou, R., Zhang, T., & Lin, Y. (2021) · Springer eBooks · doi:10.1007/978-981-16-2666-1_3 · Cited by 5
Li, C., & Zhang, B. (2022) · Neurotoxicity Research · doi:10.1007/s12640-022-00551-1 · Cited by 2
“These detrimental events promote BBB damage in AD brains, exacerbating related inflammatory responses, oxidative stress, neuronal damage, and aggravating the neurodegenerative process (Cai et al. 2018).”
BackgroundJiang, X., Han, X., Kong, T., Wu, Y., Shan, L., Yang, Z., Liu, Y., & Wang, F. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148935 · Cited by 2
Konecny, J., Misiachna, A., Chvojková, M., Kletečková, L., Kolcheva, M., Novak, M., Prchal, L., Ladislav, M., Hemelíková, K., Netolický, J., et al. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116981 · Cited by 2
New Aaptamine Analogues from Australian Marine Sponge Aaptos lobata as Mitochondrial Modulators
Makinde, E. A., Ma, L., Mellick, G. D., Ekins, M., & Feng, Y. (2025) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5c00364 · Cited by 1
AmeliMojarad, M., & AmeliMojarad, M. (2025) · Journal of NeuroVirology · doi:10.1007/s13365-025-01282-7 · Cited by 2
Popova, E., Jacobs, M. D., Hofmann‐Apitius, M., & Babaiha, N. S. (2025) · Machine Learning with Applications · doi:10.1016/j.mlwa.2025.100816 · Cited by 1
Free radical-scavenging and anti-amyloidogenic properties of chicoric acid
He, M. T., Cho, E. J., Kim, J. H., & Kim, H. Y. (2025) · Applied Biological Chemistry · doi:10.1186/s13765-025-01047-0 · Cited by 1
“However, disruptions in the function of the BBB can lead to the failure of Aβ transport from the brain to the peripheral circulation [58].”
Li, B., Xi, W. J., & Li, P. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07288-3 · Cited by 1
“The BBB forms a physical and metabolic barrier that separates the CNS from peripheral tissues, protecting the brain by maintaining a stable environment [17, 18].”
Zhao, G., Cui, B., Lu, Y., Ma, K., Gao, X., She, X., Zhu, Y., Ji, X., Yang, H. M., & Yang, H. (2026) · Biomolecules · doi:10.3390/biom16020200 · Cited by 1
“In addition, recent findings suggest that destruction of BBB integrity in AD occurs years before the onset of symptoms of cognitive impairment [36].”
Parnova, R. G., & Fock, E. M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062835 · Cited by 2
Peripheral biomarkers of neuroinflammation in Alzheimer’s disease and vascular dementia
Ouyang, X., Chia, R. S. L., Chai, Y. L., Chong, Sim, M. A., Jo, D., Arumugam, T. V., Sethi, G., Dawe, G. S., Chen, C. P., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118077 · Cited by 3
Jin, S., Guo, B., Hao, W., Su, X., Zhang, T., & Liu, C. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-25-00582 · Cited by 1
“During BBB dysfunction, a hallmark of neurodegeneration, CSF-derived Aβ isoforms and p-tau species enter systemic circulation through disrupted tight junctions and increased paracellular flux (Cai et al., 2018).”
Liu, Y., Yin, L., Zhang, P., & Li, W. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1825000 · Cited by 2
“In AD and CAA, vascular amyloid deposition, impaired clearance, and chronic perfusion de fi cits may therefore create a pro-ferroptotic endothelial environment (108, 109).”
In vitro blood–brain barrier model derived from human iPS cells and its applications
Zhang, H., Yamaguchi, T., & Kawabata, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822231-7.00003-5 · Cited by 2
The comprehensive mechanistic insight into the effects of vitamin D on dementia – a review
Jafarzadeh, J., Payahoo, L., Yousefi, M., & Barzegar, A. (2021) · Nutrition & Food Science · doi:10.1108/nfs-08-2021-0256 · Cited by 1
Metadata
- Authors
- Cai, Z., Qiao, P.-F., Wan, C.-Q., Cai, M., Zhou, N.-K., & Li, Q.
- Affiliations
- Department of Neurology, Chongqing General Hospital, Chongqing, Chongqing, China
- Corresponding author
- Cai, Zhiyou
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2018-05-30
- Volume
- 63
- Issue
- 4
- Pages
- 1223-1234
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2804234159
- Cited by
- 370
- References
- 133
- Citations by year
- 2026: 31 · 2025: 59 · 2024: 63 · 2023: 69 · 2022: 49 · 2021: 63 · 2020: 25 · 2019: 10 · 2018: 1
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- blood-brain barrier, Alzheimer's disease
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Blood-Brain Barrier, Humans, Amyloid beta-Peptides, Low Density Lipoprotein Receptor-Related Protein-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.